Cargando…
PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer
BACKGROUND: Male breast cancer is rare, as it represents less than 1% of all breast cancer cases. In addition, male breast cancer appears to have a different biology than female breast cancer. Programmed death-1 (PD-1) and its ligand, programmed death-ligand 1 (PD-L1), seem to have prognostic and pr...
Autores principales: | Manson, Quirine F., ter Hoeve, Natalie D., Buerger, Horst, Moelans, Cathy B., van Diest, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297201/ https://www.ncbi.nlm.nih.gov/pubmed/30519815 http://dx.doi.org/10.1007/s11523-018-0610-1 |
Ejemplares similares
-
Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases
por: Manson, Quirine F., et al.
Publicado: (2018) -
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
por: Severson, Tesa M., et al.
Publicado: (2018) -
Cytoplasmic DDX3 as prognosticator in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2021) -
Chromosome 17 copy number changes in male breast cancer
por: Lacle, Miangela M., et al.
Publicado: (2015) -
Methylation biomarkers for pleomorphic lobular breast cancer - a short report
por: Moelans, Cathy B., et al.
Publicado: (2015)